Cinven completed the acquisition of a 42.6% stake in Synlab for €1.2bn.

Cinven, a private equity firm, completed the acquisition of of a 42.6% stake in Synlab, an international medical diagnostics provider headquartered in Munich, Germany, for €1.2bn. Cinven and SYNLAB AG have signed an investment agreement backing the long-term strategy of the company.